Research to further scientific knowledge of the cause and treatment of the uncommon type of blood cancer, Waldenström’s macroglobulinaemia (WM), is being co-funded by the Leukaemia Foundation.
Cast your mind back to 2019, and life pre-COVID. For 56-year-old Peter D'Onghia, that meant a relentless travel schedule with his job as an academic and medical journal publisher – something that led to a delay in following up on blood test results that were, as he puts it, "a little bit odd".
The Leukaemia Foundation has welcomed news that for the first time, a targeted treatment option will now be available for Waldenström macroglobulinemia (WM) patients through the Pharmaceutical Benefits Scheme (PBS).
Living a peaceful and idyllic life on tropical Christmas Island, the Kentwell family could never have anticipated the pain blood cancer could bring to their lives.
We stand with Indigenous Australians to close the gap in health. We know we need to do better for our First Nations people living with blood cancer.
To mark Rare Disease Day, Laura Winter shares the remarkable story of how her four-year-old son, Flynn has survived an extremely rare blood cancer diagnosis.
Matthew Fogarty has spent almost five years regularly travelling to the other side of the world to collect the handful of pills that keep his blood cancer at bay.
Jack was 22 years old when he was diagnosed with a dangerous blood disorder called aplastic anaemia.
Our supporters help people going through blood cancer to make connections.
